Bausch + Lomb

SOPHIA ANTIPOLIS, France and MADISON, N.J., March 13, 2012 /PRNewswire/ -- Bausch + Lomb, the global eye health company, and NicOx S.A. (NYSE Euronext Paris: COX) today announced positive top-line results from the phase 2b study conducted with BOL?303259?X, a novel nitric oxide-donating prostaglandin F2?alpha analog, ... read more

ROCHESTER, NY -- (Marketwire) -- 06/15/11 -- Biotrue™ multi-purpose solution, made by Bausch + Lomb, keeps lenses moist for up to 20 hours, according to data presented at the 35th British Contact Lens Association Clinical Conference and Exhibition.(1) The new wettability study provides insight into a solution for ... read more

ROCHESTER, NY -- (Marketwire) -- 06/15/11 -- Today at the American Optometric Association (AOA) annual meeting, Bausch + Lomb announced plans to help make daily disposable contact lenses more accessible to kids across the U.S., just in time for the start of the new school year. "The Daily ... read more

SALT LAKE CITY, UT -- (Marketwire) -- 06/15/11 -- Bausch + Lomb, the company that brought the first soft contact lens to market 40 years ago this month, will showcase product innovations and scientific research focused on improving patient care, outcomes and quality of life this week at ... read more

SALT LAKE CITY, UT -- (Marketwire) -- 06/15/11 -- Bausch + Lomb, the company that brought the first soft contact lens to market 40 years ago this month, will showcase product innovations and scientific research focused on improving patient care, outcomes and quality of life this week at ... read more

ALISO VIEJO, CA -- (Marketwire) -- 06/01/11 -- Bausch + Lomb Storz® Ophthalmic Instruments has improved upon its existing line of vitreoretinal instrumentation with the U.S. release of StableGrip™ Vitreoretinal Instruments for comfort and control. The new StableGrip Vitreoretinal Handle features a contoured, titanium handle for lightweight balance and ... read more

ROCHESTER, NY -- (Marketwire) -- 03/24/11 -- Bausch + Lomb, the global eye health company, announces the appointment of David Mordaunt, Ph.D. as vice president, Development and Research, Bausch + Lomb Surgical. In this position, Dr. Mordaunt will be a member of the Surgical senior leadership team and will ... read more

ROCHESTER, NY -- (Marketwire) -- 03/18/11 -- Bausch + Lomb, the global eye health company, today announced the appointment of Calvin W. Roberts, M.D. to the newly created position of Chief Medical Officer (CMO). Dr. Roberts will serve as a member of the Executive Leadership Team and coordinate ... read more

ROCHESTER, NY -- (Marketwire) -- 03/11/11 -- Bausch + Lomb, the global eye health company, announced today that it is activating a relief support plan in response to the earthquake and tsunami disaster affecting Japan. "Our colleagues on the ground in Japan and in our headquarters here in the ... read more

ALISO VIEJO, CA -- (Marketwire) -- 12/08/10 -- Bausch + Lomb Storz® Ophthalmic Instruments has launched a new line of single-use cataract instrumentation in the United States. The line includes six microsurgical forceps and three cataract surgery manipulators to expand on the Bausch + Lomb Storz® Ophthalmics premium, ... read more

ROCHESTER, NY -- (Marketwire) -- 11/24/10 -- Bausch + Lomb, the global eye health company, has named Charl van Zyl as corporate vice president and commercial leader, Europe, Middle East and Africa (EMEA). "Charl is a strong, strategic leader with a proven ability to drive executional excellence," said Brent Saunders, ... read more

ALISO VIEJO, CA -- (Marketwire) -- 11/11/10 -- Bausch + Lomb Storz® Ophthalmic Instruments has enhanced its already comprehensive instrument web sites to include an e-commerce system making instrument purchases even easier for its U.S. customers. The new online ordering capabilities allow customers to build a shopping cart, adding ... read more

ROCHESTER, NY -- (Marketwire) -- 10/29/10 -- Bausch + Lomb, the global eye health company, has named Mariano García-Valiño to the newly created role of corporate vice president and president, Latin America, effective immediately. "Mariano has extensive experience in developing high-performing health care businesses in Latin America," said Brent ... read more

CHICAGO, IL -- (Marketwire) -- 10/15/10 -- The Pediatric Cataract Initiative (www.PediatricCataract.org) has set a November 15 deadline for receipt of applications for its inaugural single small research grant. US$75,000 will be awarded to a qualified individual, institution or organization investigating the causes of pediatric cataract and/or improved ... read more

ALISO VIEJO, CA -- (Marketwire) -- 09/29/10 -- Bausch + Lomb Storz® Ophthalmic Instruments announced a new innovation in incision technology with the U.S. release of the Tru-Size™ Diamond Knife. This innovative diamond knife enhances the already popular Storz® profile diamond knife with incision widths engraved on the diamond ... read more

ALISO VIEJO, CA -- (Marketwire) -- 09/21/10 -- Bausch + Lomb Storz® Ophthalmic Instruments announced the U.S. release of the E2427 Whitman Double-Ended LRI Marker for LRI procedures. This double-ended LRI marker is designed using chord lengths for treatment parameters as opposed to degrees. The two astigmatic dials cover ... read more

ROCHESTER, NY -- (Marketwire) -- 09/20/10 -- Bausch + Lomb, the global eye health company, has announced that it has concluded its worldwide acquisition of the assets and intellectual property for Miochol®-E from Affiliates of Novartis AG. "Closure of this acquisition is a terrific gain for Bausch + Lomb ... read more

ROCHESTER, NY -- (Marketwire) -- 09/09/10 -- Bausch + Lomb, the global eye health company, has named Daniel M. Wechsler as corporate vice president and global president of its Pharmaceuticals business. "Dan has a strong track record as a senior executive driving high performance in global health care companies," ... read more

ROCHESTER, NY -- (Marketwire) -- 09/08/10 -- The Pediatric Cataract Initiative (www.PediatricCataract.org) is now accepting applicants for its inaugural single small research grant. US$75,000 will be awarded to a qualified individual, institution or organization investigating the causes of pediatric cataract and/or improved treatment tools and protocols. The submission ... read more

ROCHESTER, NY -- (Marketwire) -- 09/03/10 -- Bausch + Lomb, the global eye health company, has announced that it has concluded its acquisition of a portion of the assets and intellectual property for Miochol®-E from Affiliates of Novartis AG. Bausch + Lomb intends to complete the acquisition of ... read more